Summary Description of the Company (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 14, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Subsidiary, Sale of Stock [Line Items] | |||
| Gross proceeds | $ 70,000 | ||
| IPO [Member] | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| IPO shares issued | 5,000,000.0 | ||
| Share price | $ 14.00 | ||
| Gross proceeds | $ 70,000 | ||
| Underwriting fees | 4,900 | ||
| Deferred offering cost | $ 700 | ||
| IPO [Member] | Parent Company [Member] | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| IPO shares issued | 571,428 | ||
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|